ADHERE-LPV Advancing Delivery of High-Quality Evidence-Based Respiratory Efforts in Lung-Protective Ventilation

July 7, 2025 updated by: University of Minnesota
This study is a cluster randomized trial across 10 hospitals, stratified by hospital size (hospitals with greater than 100 mechanically ventilated patients a year will be classified as large, while those with 100 or fewer will be classified as small). Randomization will occur at the hospital level, ensuring an even distribution of large and small hospitals between study arms. Hospitals assigned to the intervention group will implement an EHR-based strategy designed to enhance adherence to lung-protective ventilation (LPV) for a 9-month intervention period, after which the strategy will be rolled out to all hospitals. The intervention focuses on modifying the ventilator order within the Electronic Health Record (EHR) to encourage default settings aligned with LPV principles. This study design allows for comparison of patient outcomes before and after implementation within each hospital while also enabling simultaneous comparisons between hospitals that have and have not yet received the intervention. The cluster randomization approach is necessary, given the order is controlled at the hospital level.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

1125

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Nick Ingraham, MD, MS
  • Phone Number: (612) 624-0999
  • Email: ingra107@umn.edu

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • Recruiting
        • University of Minnesota
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 18 and over
  • Requires mechanical ventilation

Exclusion Criteria:

  • The patient opted out of research
  • The mode ordered does not require a set tidal volume
  • Requires ECMO prior to ICU admission
  • Data during the use of ECMO
  • Hospitalization was for an elective surgery
  • The duration of mechanical ventilation was less than 12 hours (these are not the patients that would benefit from LPV)
  • Admission code documentation of Do Not Intubate. While rare, in situations where a patient was intubated but whose preferences are contradictory to the current care, mechanical ventilation is managed differently while undergoing goals of care conversations.
  • Height was documented as less than 4 feet given the PBW formula was not validated below this height.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard of Care Ventilator
Patients in one of the 10 participating hospitals who require mechanical ventilation randomized to the current ventilator order that is used across the health system.
Current ventilator order used by control hospitals
Experimental: Experimental Ventilator
Patients in one of the 10 participating hospitals who require mechanical ventilation randomized to a new ventilation order

The new ventilator order (intervention) was developed using economic behavior theory to decrease the cognitive burden on the ordering provider while enhancing the operability of the order itself. The strategy resulted in a new ventilator order that includes the following changes:

  1. Automatic calculation of the PBW based on the most recent height
  2. If the height is not available, an order to obtain a height will be generated and the choice of tidal volume will be based on cc/kg PBW
  3. Simplify ventilator modes to accurately reflect the standard of care
  4. Reduce duplicative information in the monitoring and comments portion of the order
  5. Cascade ventilator orders based on mode to enhance visualization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
lung-protective ventilation
Time Frame: 4 hours
The primary outcome is a binary indicator of lung-protective ventilation (ventilator set at ≤ 8 cc/kg) at the first documented set tidal volume after 4 hours.
4 hours

Secondary Outcome Measures

Outcome Measure
Time Frame
Rate (hours) with set tidal volume < 6cc/kg PBW
Time Frame: 72 hours
72 hours
Rate (hours) exposure to >8 cc/kg PBW
Time Frame: 72 hours
72 hours
Rate (hours) exposure to >10 cc/kg PBW
Time Frame: 72 hours
72 hours
Time to adhere to ≤ 8 cc/kg per day: Of all patients set to >8 cc/kg per day, how long did it take for the patient to receive ≤ 8 cc/kg per day?
Time Frame: 72 hours
72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2025

Primary Completion (Estimated)

July 16, 2026

Study Completion (Estimated)

July 16, 2026

Study Registration Dates

First Submitted

March 18, 2025

First Submitted That Met QC Criteria

March 18, 2025

First Posted (Actual)

March 26, 2025

Study Record Updates

Last Update Posted (Actual)

July 9, 2025

Last Update Submitted That Met QC Criteria

July 7, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • ADHERE-LPV

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ventilation

Clinical Trials on control ventilator

Subscribe